Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

KLRA vs SLS: stock comparison and AI forecast

Kailera Therapeutics, Inc. (KLRA) and Sellas Life Sciences Group, Inc. (SLS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

KLRA Kailera Therapeutics, Inc.

Market Cap
$1.58B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

SLS Sellas Life Sciences Group, Inc.

Market Cap
$1.58B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

KLRA · SLS

Key facts

  • KLRA and SLS have similar market capitalizations ($1.58B and $1.58B).
  • SLS carries 0.06 times debt per unit of equity, against 0.05 times for KLRA.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricKLRASLS
Market Cap$1.58B$1.58B
P/B Ratio1.53x11.48x
EPS–$-0.23
Book Value/Share$7.95$0.80

Profitability & Margins

MetricKLRASLS
ROE–-23.6%
ROA–-22.3%
ROIC–-25.6%

Financial Health

MetricKLRASLS
Current Ratio21.84x18.83x
D/E Ratio0.05x0.06x
Financial Leverage1.05x1.06x
Interest Coverage–-122.1x
Working Capital$878M$135M

Cash Flow

MetricKLRASLS
Operating Cash Flow–-$28M

Income Statement

MetricKLRASLS
Operating Income–-$35M
Net Income–-$32M
R&D Expense–$20M
SG&A Expense–$12M
Cost of Goods Sold–$0.00M

Dividend & Shareholder Information

MetricKLRASLS
Shares Outstanding130M173M
FAQ

KLRA vs SLS: stock comparison and AI forecast

Which is bigger, KLRA or SLS?

KLRA and SLS have similar market capitalizations ($1.58B and $1.58B).

Which one does Intratio's AI model rank higher, KLRA or SLS?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.